Using blood markers to detect Alzheimer's disease early in Colombia
IMPLEMENTATION OF BIOFLUID MARKERS FOR EARLY DETECTION OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES IN COLOMBIA
This study is working on finding new blood tests to help spot Alzheimer's disease and other brain disorders early, so that people in Colombia can get better care and treatment sooner.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Antioquia NIH-funded |
| Lab location | 1 site (Medellin, Colombia) |
| Project ID | NIH-10537769 on NIH RePORTER |
What this research studies
This research focuses on developing and implementing biofluid markers, specifically from blood samples, to facilitate the early detection of Alzheimer's disease and other neurodegenerative diseases in Colombia. The project aims to enhance the capabilities of the Neuroscience Group at the University of Antioquia by utilizing their extensive biobank of biological samples from familial Alzheimer's disease. By establishing the necessary infrastructure for biomarker detection, the research seeks to improve diagnosis, prevention, and treatment options for patients in the region.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a family history of Alzheimer's disease or those showing early signs of neurodegenerative conditions.
Not a fit: Patients without a familial history of Alzheimer's disease or those who do not exhibit any symptoms of neurodegenerative diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of Alzheimer's disease, improving patient outcomes and treatment options.
How similar studies have performed: Other research has shown promise in using biofluid markers for early detection of Alzheimer's disease, indicating that this approach has potential for success.
Where this research is happening
Medellin, Colombia
- University of Antioquia — Medellin, Colombia (Active)
Researchers
- Principal investigator: Cardona-Gómez, Gloria Patricia — University of Antioquia
- Study coordinator: Cardona-Gómez, Gloria Patricia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.